United States EU Japan China India and Southeast Asia Pulmonary Hypertension Market Size Status and Forecast 2021

United States, EU, Japan, China, India and Southeast Asia Pulmonary Hypertension Market Size, Status and Forecast 2021

1 Industry Overview of Pulmonary Hypertension

1.1 Pulmonary Hypertension Market Overview

1.1.1 Pulmonary Hypertension Product Scope

1.1.2 Market Status and Outlook

1.2 Global Pulmonary Hypertension Market Size and Analysis by Regions

1.2.1 United States

1.2.2 EU

1.2.3 Japan

1.2.4 China

1.2.5 India

1.2.6 Southeast Asia

1.3 Pulmonary Hypertension Market by End Users/Application

1.3.1 Application 1

1.3.2 Application 2

1.3.3 Application 3

2 Global Pulmonary Hypertension Competition Analysis by Players

2.1 Pulmonary Hypertension Market Size (Value) by Players (2015-2016)

2.2 Competitive Status and Trend

2.2.1 Market Concentration Rate

2.2.2 Product/Service Differences

2.2.3 New Entrants

2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

3.1 Actelion

3.1.1 Company Profile

3.1.2 Main Business/Business Overview

3.1.3 Products, Services and Solutions

3.1.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.1.5 Recent Developments

3.2 Bayer

3.2.1 Company Profile

3.2.2 Main Business/Business Overview

3.2.3 Products, Services and Solutions

3.2.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.2.5 Recent Developments

3.3 GlaxoSmithKline

3.3.1 Company Profile

3.3.2 Main Business/Business Overview

3.3.3 Products, Services and Solutions

3.3.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.3.5 Recent Developments

3.4 United Therapeutics

3.4.1 Company Profile

3.4.2 Main Business/Business Overview

3.4.3 Products, Services and Solutions

3.4.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.4.5 Recent Developments

3.5 Aires Pharmaceuticals

3.5.1 Company Profile

3.5.2 Main Business/Business Overview

3.5.3 Products, Services and Solutions

3.5.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.5.5 Recent Developments

3.6 Arena Pharmaceuticals

3.6.1 Company Profile

3.6.2 Main Business/Business Overview

3.6.3 Products, Services and Solutions

3.6.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.6.5 Recent Developments

3.7 Bial

3.7.1 Company Profile

3.7.2 Main Business/Business Overview

3.7.3 Products, Services and Solutions

3.7.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.7.5 Recent Developments

3.8 DEKA

3.8.1 Company Profile

3.8.2 Main Business/Business Overview

3.8.3 Products, Services and Solutions

3.8.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.8.5 Recent Developments

3.9 Dong-A ST

3.9.1 Company Profile

3.9.2 Main Business/Business Overview

3.9.3 Products, Services and Solutions

3.9.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.9.5 Recent Developments

3.10 Gilead

3.10.1 Company Profile

3.10.2 Main Business/Business Overview

3.10.3 Products, Services and Solutions

3.10.4 Pulmonary Hypertension Revenue (Value) (2011-2016)

3.10.5 Recent Developments

3.11 Merck

3.12 Northern Therapeutics

3.13 Novartis

3.14 Pfizer

3.15 PhaseBio

3.16 Radikal Therapeutics

3.17 Reata Pharmaceuticals

3.18 SteadyMed

4 Global Pulmonary Hypertension Market Size by Application (2011-2016)

4.1 Global Pulmonary Hypertension Market Size by Application (2011-2016)

4.2 Potential Application of Pulmonary Hypertension in Future

4.3 Top Consumer/End Users of Pulmonary Hypertension

5 United States Pulmonary Hypertension Development Status and Outlook

5.1 United States Pulmonary Hypertension Market Size (2011-2016)

5.2 United States Pulmonary Hypertension Market Size and Market Share by Players (2015-2016)

6 EU Pulmonary Hypertension Development Status and Outlook

6.1 EU Pulmonary Hypertension Market Size (2011-2016)

6.2 EU Pulmonary Hypertension Market Size and Market Share by Players (2015-2016)

7 Japan Pulmonary Hypertension Development Status and Outlook

7.1 Japan Pulmonary Hypertension Market Size (2011-2016)

7.2 Japan Pulmonary Hypertension Market Size and Market Share by Players (2015-2016)

8 China Pulmonary Hypertension Development Status and Outlook

8.1 China Pulmonary Hypertension Market Size (2011-2016)

8.2 China Pulmonary Hypertension Market Size and Market Share by Players (2015-2016)

9 India Pulmonary Hypertension Development Status and Outlook

9.1 India Pulmonary Hypertension Market Size (2011-2016)

9.2 India Pulmonary Hypertension Market Size and Market Share by Players (2015-2016)

10 Southeast Asia Pulmonary Hypertension Development Status and Outlook

10.1 Southeast Asia Pulmonary Hypertension Market Size (2011-2016)

10.2 Southeast Asia Pulmonary Hypertension Market Size and Market Share by Players (2015-2016)

11 Market Forecast by Regions and Application (2016-2021)

11.1 Global Pulmonary Hypertension Market Size (Value) by Regions (2016-2021)

11.2 Global Pulmonary Hypertension Market Size (Value) by Application (2016-2021)

11.3 The Market Drivers in Future

12 Pulmonary Hypertension Market Dynamics

12.1 Pulmonary Hypertension Market Opportunities

12.2 Pulmonary Hypertension Challenge and Risk

12.2.1 Competition from Opponents

12.2.2 Downside Risks of Economy

12.3 Pulmonary Hypertension Market Constraints and Threat

12.3.1 Threat from Substitute

12.3.2 Government Policy

12.3.3 Technology Risks

12.4 Pulmonary Hypertension Market Driving Force

12.4.1 Growing Demand from Emerging Markets

12.4.2 Potential Application

13 Market Effect Factors Analysis

13.1 Technology Progress/Risk

13.1.1 Substitutes

13.1.2 Technology Progress in Related Industry

13.2 Consumer Needs Trend/Customer Preference

13.3 External Environmental Change

13.3.1 Economic Fluctuations

13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Pulmonary Hypertension Product Scope

Figure Global Pulmonary Hypertension Market Size (2011-2016)

Table Global Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Figure Global Pulmonary Hypertension Market Share by Regions in 2015

Figure United States Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Figure EU Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Figure Japan Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Figure China Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Figure India Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Figure Southeast Asia Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Figure Global Pulmonary Hypertension Market Share by Application in 2015

Figure Pulmonary Hypertension Market Size and Growth Rate in Applications 1 (2011-2016)

Figure Pulmonary Hypertension Market Size and Growth Rate in Applications 2 (2011-2016)

Figure Pulmonary Hypertension Market Size and Growth Rate in Applications 3 (2011-2016)

Table Pulmonary Hypertension Market Size (Value) by Players (2015-2016)

Figure Pulmonary Hypertension Market Size Share by Players in 2015

Figure Pulmonary Hypertension Market Size Share by Players in 2016

Table Actelion Basic Information List

Table Pulmonary Hypertension Business Revenue of Actelion (2011-2016)

Figure Actelion Pulmonary Hypertension Business Revenue Market Share in 2015

Table Bayer Basic Information List

Table Pulmonary Hypertension Business Revenue of Bayer (2011-2016)

Figure Bayer Pulmonary Hypertension Business Revenue Market Share in 2015

Table GlaxoSmithKline Basic Information List

Table Pulmonary Hypertension Business Revenue of GlaxoSmithKline (2011-2016)

Figure GlaxoSmithKline Pulmonary Hypertension Business Revenue Market Share in 2015

Table United Therapeutics Basic Information List

Table Pulmonary Hypertension Business Revenue of United Therapeutics (2011-2016)

Figure United Therapeutics Pulmonary Hypertension Business Revenue Market Share in 2015

Table Aires Pharmaceuticals Basic Information List

Table Pulmonary Hypertension Business Revenue of Aires Pharmaceuticals (2011-2016)

Figure Aires Pharmaceuticals Pulmonary Hypertension Business Revenue Market Share in 2015

Table Arena Pharmaceuticals Basic Information List

Table Pulmonary Hypertension Business Revenue of Arena Pharmaceuticals (2011-2016)

Figure Arena Pharmaceuticals Pulmonary Hypertension Business Revenue Market Share in 2015

Table Bial Basic Information List

Table Pulmonary Hypertension Business Revenue of Bial (2011-2016)

Figure Bial Pulmonary Hypertension Business Revenue Market Share in 2015

Table DEKA Basic Information List

Table Pulmonary Hypertension Business Revenue of DEKA (2011-2016)

Figure DEKA Pulmonary Hypertension Business Revenue Market Share in 2015

Table Dong-A ST Basic Information List

Table Pulmonary Hypertension Business Revenue of Dong-A ST (2011-2016)

Figure Dong-A ST Pulmonary Hypertension Business Revenue Market Share in 2015

Table Gilead Basic Information List

Table Pulmonary Hypertension Business Revenue of Gilead (2011-2016)

Figure Gilead Pulmonary Hypertension Business Revenue Market Share in 2015

Table Merck Basic Information List

Table Pulmonary Hypertension Business Revenue of Merck (2011-2016)

Figure Merck Pulmonary Hypertension Business Revenue Market Share in 2015

Table Northern Therapeutics Basic Information List

Table Pulmonary Hypertension Business Revenue of Northern Therapeutics (2011-2016)

Figure Northern Therapeutics Pulmonary Hypertension Business Revenue Market Share in 2015

Table Novartis Basic Information List

Table Pulmonary Hypertension Business Revenue of Novartis (2011-2016)

Figure Novartis Pulmonary Hypertension Business Revenue Market Share in 2015

Table Pfizer Basic Information List

Table Pulmonary Hypertension Business Revenue of Pfizer (2011-2016)

Figure Pfizer Pulmonary Hypertension Business Revenue Market Share in 2015

Table PhaseBio Basic Information List

Table Pulmonary Hypertension Business Revenue of PhaseBio (2011-2016)

Figure PhaseBio Pulmonary Hypertension Business Revenue Market Share in 2015

Table Radikal Therapeutics Basic Information List

Table Pulmonary Hypertension Business Revenue of Radikal Therapeutics (2011-2016)

Figure Radikal Therapeutics Pulmonary Hypertension Business Revenue Market Share in 2015

Table Reata Pharmaceuticals Basic Information List

Table Pulmonary Hypertension Business Revenue of Reata Pharmaceuticals (2011-2016)

Figure Reata Pharmaceuticals Pulmonary Hypertension Business Revenue Market Share in 2015

Table SteadyMed Basic Information List

Table Pulmonary Hypertension Business Revenue of SteadyMed (2011-2016)

Figure SteadyMed Pulmonary Hypertension Business Revenue Market Share in 2015

Table Global Pulmonary Hypertension Market Size by Application (2011-2016)

Figure Global Pulmonary Hypertension Market Size by Application in 2011

Figure Global Pulmonary Hypertension Market Size by Application in 2012

Figure Global Pulmonary Hypertension Market Size by Application in 2013

Figure Global Pulmonary Hypertension Market Size by Application in 2014

Figure Global Pulmonary Hypertension Market Size by Application in 2015

Figure Global Pulmonary Hypertension Market Size by Application in 2016

Table Top Consumer/End Users of Pulmonary Hypertension

Figure United States Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Table United States Pulmonary Hypertension Market Size by Players (2011-2016)

Figure United States Pulmonary Hypertension Market Size Share by Players in 2015

Figure United States Pulmonary Hypertension Market Size Share by Players in 2016

Figure EU Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Table EU Pulmonary Hypertension Market Size by Players (2011-2016)

Figure EU Pulmonary Hypertension Market Size Share by Players in 2015

Figure EU Pulmonary Hypertension Market Size Share by Players in 2016

Figure Japan Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Table Japan Pulmonary Hypertension Market Size by Players (2011-2016)

Figure Japan Pulmonary Hypertension Market Size Share by Players in 2015

Figure Japan Pulmonary Hypertension Market Size Share by Players in 2016

Figure China Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Table China Pulmonary Hypertension Market Size by Players (2011-2016)

Figure China Pulmonary Hypertension Market Size Share by Players in 2015

Figure China Pulmonary Hypertension Market Size Share by Players in 2016

Figure India Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Table India Pulmonary Hypertension Market Size by Players (2011-2016)

Figure India Pulmonary Hypertension Market Size Share by Players in 2015

Figure India Pulmonary Hypertension Market Size Share by Players in 2016

Figure Southeast Asia Pulmonary Hypertension Market Size and Growth Rate by Regions (2011-2016)

Table Southeast Asia Pulmonary Hypertension Market Size by Players (2011-2016)

Figure Southeast Asia Pulmonary Hypertension Market Size Share by Players in 2015

Figure Southeast Asia Pulmonary Hypertension Market Size Share by Players in 2016

Figure Global Pulmonary Hypertension Market Size (Value) by Regions (2016-2021)

Table Global Pulmonary Hypertension Market Size by Regions (2016-2021)

Figure Global Pulmonary Hypertension Market Size Share by Regions in 2017

Figure Global Pulmonary Hypertension Market Size Share by Regions in 2021

Table Global Pulmonary Hypertension Market Size by Application (2016-2021)

Figure Global Pulmonary Hypertension Market Size by Application in 2017

Figure Global Pulmonary Hypertension Market Size by Application in 2021